rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2001-5-31
|
pubmed:abstractText |
Human immunodeficiency virus type-1 (HIV-1) cytotoxic T lymphocyte (CTL) epitopes have largely been defined in Caucasian populations infected with clade B virus. Identification of potentially protective CTL epitopes in non-B clade-infected African subjects is important for vaccine development. In a study of CTL responses in clade A-infected Gambians, using cytotoxicity, interferon-gamma (IFN-gamma) enzyme-linked immunospot (ELISpot) and HLA-B53-peptide tetramer assays, we identified three HLA-B53-restricted epitopes in HIV-1 gag p24. CTL specific for an epitope in a highly immunogenic region of the p24 protein showed no cross-reactivity to other HIV-1 clades. Two of the epitopes would not have been predicted from the peptide-binding motif due to the absence of a proline anchor at position 2. Structural analysis of HLA-B53 and its relative, HLA B35, enabled us to re-define the peptide-binding motif to include other P2 anchors. These results demonstrate the value of combined immunological and structural analyses in defining novel CTL epitopes and have implications for HIV-1 vaccine design.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, gag,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Core Protein p24,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B53 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/gag Gene Products, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/p17 protein, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0014-2980
|
pubmed:author |
pubmed-author:DeGleriaKK,
pubmed-author:DorrellLL,
pubmed-author:GillespieGG,
pubmed-author:JayeAA,
pubmed-author:JonesE YEY,
pubmed-author:LepinEE,
pubmed-author:McMichaelAA,
pubmed-author:NjaiHH,
pubmed-author:RostronTT,
pubmed-author:Rowland-JonesSS,
pubmed-author:SaballySS,
pubmed-author:WhittleHH,
pubmed-author:WillcoxB EBE
|
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1747-56
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11385619-Amino Acid Sequence,
pubmed-meshheading:11385619-Cell Line, Transformed,
pubmed-meshheading:11385619-Cross Reactions,
pubmed-meshheading:11385619-Epitopes, T-Lymphocyte,
pubmed-meshheading:11385619-Gene Products, gag,
pubmed-meshheading:11385619-HIV Antigens,
pubmed-meshheading:11385619-HIV Core Protein p24,
pubmed-meshheading:11385619-HIV Infections,
pubmed-meshheading:11385619-HIV-1,
pubmed-meshheading:11385619-HIV-2,
pubmed-meshheading:11385619-HLA Antigens,
pubmed-meshheading:11385619-Humans,
pubmed-meshheading:11385619-Molecular Sequence Data,
pubmed-meshheading:11385619-Peptides,
pubmed-meshheading:11385619-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:11385619-Viral Proteins,
pubmed-meshheading:11385619-gag Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2001
|
pubmed:articleTitle |
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
|
pubmed:affiliation |
MRC Human Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, GB.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|